Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.5.1.3 (
dihydrofolate reductase
)
5,819
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Cyclin E1 gene (CCNE1) is an ideal model to explore the mechanisms that control the transcription of cell cycle-regulated genes whose expression rises transiently before entry into S phase. E2F-dependent regulation of the CCNE1 promoter was shown to correlate with changes in the level of H3-K9 acetylation/methylation of nucleosomal histones positioned at the transcriptional start site region. Here we show that, upon growth stimulation, the same region is subject to variations of H3-R17 and H3-R26 methylation that correlate with the recruitment of
coactivator-associated arginine methyltransferase 1
(
CARM1
) onto the CCNE1 and
DHFR
promoters. Accordingly,
CARM1
-deficient cells lack these modifications and present lowered levels and altered kinetics of CCNE1 and
DHFR
mRNA expression. Consistently, reporter gene assays demonstrate that
CARM1
functions as a transcriptional coactivator for their E2F1/DP1-stimulated expression.
CARM1
recruitment at the CCNE1 gene requires activator E2Fs and ACTR, a member of the p160 coactivator family that is frequently overexpressed in human breast cancer. Finally, we show that grade-3 breast tumors present coelevated mRNA levels of ACTR and
CARM1
, along with their transcriptional target CCNE1. All together, our results indicate that
CARM1
is an important regulator of the CCNE1 gene.
...
PMID:Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene. 1693 73